A perspective for sequencing familial hypercholesterolaemia in African Americans

Michelle L. Wright, David Housman, Jacquelyn Taylor

Research output: Contribution to journalReview article

Abstract

African Americans suffer disproportionately from poor cardiovascular health outcomes despite similar proportions of African Americans and Americans of European ancestry experiencing elevated cholesterol levels. Some of the variation in cardiovascular outcomes is due to confounding effects of other risk factors, such as hypertension and genetic influence. However, genetic variants found to contribute to variation in serum cholesterol levels in populations of European ancestry are less likely to replicate in populations of African ancestry. To date, there has been limited follow-up on variant discrepancies or on identifying variants that exist in populations of African ancestry. African and African-American populations have the highest levels of genetic heterogeneity, which is a factor that must be considered when evaluating genetic variants in the burgeoning era of personalised medicine. Many of the large published studies identifying genetic variants associated with disease risk have evaluated populations of mostly European ancestry and estimated risk in other populations based on these findings. The purpose of this paper is to provide a perspective, using familial hypercholesterolaemia as an exemplar, that studies evaluating genetic variation focused within minority populations are necessary to identify factors that contribute to disparities in health outcomes and realise the full utility of personalised medicine.

Original languageEnglish (US)
Article number16012
Journalnpj Genomic Medicine
Volume1
DOIs
StatePublished - May 11 2016

Fingerprint

Hyperlipoproteinemia Type II
African Americans
Population
Precision Medicine
Genetic Heterogeneity
Health
Hypercholesterolemia
Cholesterol
Hypertension
Serum

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Genetics(clinical)

Cite this

A perspective for sequencing familial hypercholesterolaemia in African Americans. / Wright, Michelle L.; Housman, David; Taylor, Jacquelyn.

In: npj Genomic Medicine, Vol. 1, 16012, 11.05.2016.

Research output: Contribution to journalReview article

@article{dd7910afecd545c0bbcb2ec63bfa0e9e,
title = "A perspective for sequencing familial hypercholesterolaemia in African Americans",
abstract = "African Americans suffer disproportionately from poor cardiovascular health outcomes despite similar proportions of African Americans and Americans of European ancestry experiencing elevated cholesterol levels. Some of the variation in cardiovascular outcomes is due to confounding effects of other risk factors, such as hypertension and genetic influence. However, genetic variants found to contribute to variation in serum cholesterol levels in populations of European ancestry are less likely to replicate in populations of African ancestry. To date, there has been limited follow-up on variant discrepancies or on identifying variants that exist in populations of African ancestry. African and African-American populations have the highest levels of genetic heterogeneity, which is a factor that must be considered when evaluating genetic variants in the burgeoning era of personalised medicine. Many of the large published studies identifying genetic variants associated with disease risk have evaluated populations of mostly European ancestry and estimated risk in other populations based on these findings. The purpose of this paper is to provide a perspective, using familial hypercholesterolaemia as an exemplar, that studies evaluating genetic variation focused within minority populations are necessary to identify factors that contribute to disparities in health outcomes and realise the full utility of personalised medicine.",
author = "Wright, {Michelle L.} and David Housman and Jacquelyn Taylor",
year = "2016",
month = "5",
day = "11",
doi = "10.1038/npjgenmed.2016.12",
language = "English (US)",
volume = "1",
journal = "npj Genomic Medicine",
issn = "2056-7944",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A perspective for sequencing familial hypercholesterolaemia in African Americans

AU - Wright, Michelle L.

AU - Housman, David

AU - Taylor, Jacquelyn

PY - 2016/5/11

Y1 - 2016/5/11

N2 - African Americans suffer disproportionately from poor cardiovascular health outcomes despite similar proportions of African Americans and Americans of European ancestry experiencing elevated cholesterol levels. Some of the variation in cardiovascular outcomes is due to confounding effects of other risk factors, such as hypertension and genetic influence. However, genetic variants found to contribute to variation in serum cholesterol levels in populations of European ancestry are less likely to replicate in populations of African ancestry. To date, there has been limited follow-up on variant discrepancies or on identifying variants that exist in populations of African ancestry. African and African-American populations have the highest levels of genetic heterogeneity, which is a factor that must be considered when evaluating genetic variants in the burgeoning era of personalised medicine. Many of the large published studies identifying genetic variants associated with disease risk have evaluated populations of mostly European ancestry and estimated risk in other populations based on these findings. The purpose of this paper is to provide a perspective, using familial hypercholesterolaemia as an exemplar, that studies evaluating genetic variation focused within minority populations are necessary to identify factors that contribute to disparities in health outcomes and realise the full utility of personalised medicine.

AB - African Americans suffer disproportionately from poor cardiovascular health outcomes despite similar proportions of African Americans and Americans of European ancestry experiencing elevated cholesterol levels. Some of the variation in cardiovascular outcomes is due to confounding effects of other risk factors, such as hypertension and genetic influence. However, genetic variants found to contribute to variation in serum cholesterol levels in populations of European ancestry are less likely to replicate in populations of African ancestry. To date, there has been limited follow-up on variant discrepancies or on identifying variants that exist in populations of African ancestry. African and African-American populations have the highest levels of genetic heterogeneity, which is a factor that must be considered when evaluating genetic variants in the burgeoning era of personalised medicine. Many of the large published studies identifying genetic variants associated with disease risk have evaluated populations of mostly European ancestry and estimated risk in other populations based on these findings. The purpose of this paper is to provide a perspective, using familial hypercholesterolaemia as an exemplar, that studies evaluating genetic variation focused within minority populations are necessary to identify factors that contribute to disparities in health outcomes and realise the full utility of personalised medicine.

UR - http://www.scopus.com/inward/record.url?scp=85016169218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016169218&partnerID=8YFLogxK

U2 - 10.1038/npjgenmed.2016.12

DO - 10.1038/npjgenmed.2016.12

M3 - Review article

VL - 1

JO - npj Genomic Medicine

JF - npj Genomic Medicine

SN - 2056-7944

M1 - 16012

ER -